Cargando…
Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170128/ https://www.ncbi.nlm.nih.gov/pubmed/25249681 http://dx.doi.org/10.2337/dc14-1482 |
| _version_ | 1782335790619033600 |
|---|---|
| author | Sarkar, Gayatri Alattar, May Brown, Rebecca J. Quon, Michael J. Harlan, David M. Rother, Kristina I. |
| author_facet | Sarkar, Gayatri Alattar, May Brown, Rebecca J. Quon, Michael J. Harlan, David M. Rother, Kristina I. |
| author_sort | Sarkar, Gayatri |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4170128 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-41701282015-10-01 Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670 Sarkar, Gayatri Alattar, May Brown, Rebecca J. Quon, Michael J. Harlan, David M. Rother, Kristina I. Diabetes Care e-Letters: Comments and Responses American Diabetes Association 2014-10 2014-09-10 /pmc/articles/PMC4170128/ /pubmed/25249681 http://dx.doi.org/10.2337/dc14-1482 Text en © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. |
| spellingShingle | e-Letters: Comments and Responses Sarkar, Gayatri Alattar, May Brown, Rebecca J. Quon, Michael J. Harlan, David M. Rother, Kristina I. Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670 |
| title | Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670 |
| title_full | Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670 |
| title_fullStr | Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670 |
| title_full_unstemmed | Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670 |
| title_short | Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670 |
| title_sort | response to comment on sarkar et al. exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes. diabetes care 2014;37:666–670 |
| topic | e-Letters: Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170128/ https://www.ncbi.nlm.nih.gov/pubmed/25249681 http://dx.doi.org/10.2337/dc14-1482 |
| work_keys_str_mv | AT sarkargayatri responsetocommentonsarkaretalexenatidetreatmentfor6monthsimprovesinsulinsensitivityinadultswithtype1diabetesdiabetescare201437666670 AT alattarmay responsetocommentonsarkaretalexenatidetreatmentfor6monthsimprovesinsulinsensitivityinadultswithtype1diabetesdiabetescare201437666670 AT brownrebeccaj responsetocommentonsarkaretalexenatidetreatmentfor6monthsimprovesinsulinsensitivityinadultswithtype1diabetesdiabetescare201437666670 AT quonmichaelj responsetocommentonsarkaretalexenatidetreatmentfor6monthsimprovesinsulinsensitivityinadultswithtype1diabetesdiabetescare201437666670 AT harlandavidm responsetocommentonsarkaretalexenatidetreatmentfor6monthsimprovesinsulinsensitivityinadultswithtype1diabetesdiabetescare201437666670 AT rotherkristinai responsetocommentonsarkaretalexenatidetreatmentfor6monthsimprovesinsulinsensitivityinadultswithtype1diabetesdiabetescare201437666670 |